Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
national blog main
biotech
national top stories
boston blog main
boston top stories
fda
national
new york blog main
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
celgene
clinical trials
deals
detroit blog main
detroit top stories
drugs
gene editing
indiana blog main
indiana top stories
johnson & johnson
m&a
new york top stories
president trump
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
ac immune
achaogen
What
biopharma
5
×
bio
drug
medicine
roundup
therapeutics
administration
announced
approval
bacteria
betting
billion
blueprint
business
car
celgene
cheaper
colleagues
company
congress
congressional
crispr
deal
disease
duchenne
executives
exited
exome
fda
feud
fighting
foreign
gene
government
group
health
historic
hundreds
industry
infections
Language
unset
Current search:
biopharma
×
" life sciences "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections